Compare ALVO & PRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALVO | PRG |
|---|---|---|
| Founded | 2013 | 2020 |
| Country | Luxembourg | United States |
| Employees | 1460 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | N/A | 2020 |
| Metric | ALVO | PRG |
|---|---|---|
| Price | $4.17 | $38.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $8.00 | ★ $50.00 |
| AVG Volume (30 Days) | ★ 721.1K | 365.0K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.45% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.89 |
| Revenue | N/A | ★ $2,409,223,000.00 |
| Revenue This Year | $13.28 | $23.77 |
| Revenue Next Year | $18.63 | $7.91 |
| P/E Ratio | ★ $18.20 | $41.72 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.94 | $25.80 |
| 52 Week High | $9.94 | $41.14 |
| Indicator | ALVO | PRG |
|---|---|---|
| Relative Strength Index (RSI) | 64.02 | 63.12 |
| Support Level | $3.09 | $32.30 |
| Resistance Level | $5.46 | $38.57 |
| Average True Range (ATR) | 0.28 | 1.48 |
| MACD | 0.11 | 0.13 |
| Stochastic Oscillator | 76.06 | 77.00 |
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.